DURAMED PHARMACEUTICALS INC
10-Q, EX-27, 2000-11-14
PHARMACEUTICAL PREPARATIONS
Previous: DURAMED PHARMACEUTICALS INC, 10-Q, 2000-11-14
Next: COMMON GOAL HEALTH CARE PARTICIPATING MORTGAGE FUND L P, 10QSB, 2000-11-14



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FINANCIAL
STATEMENTS FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2000 AND IS QUALIFIED IN
ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JUL-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                           4,000
<SECURITIES>                                         0
<RECEIVABLES>                               15,661,427
<ALLOWANCES>                                 1,179,000
<INVENTORY>                                 28,218,064
<CURRENT-ASSETS>                            47,620,241
<PP&E>                                      51,849,741
<DEPRECIATION>                              23,018,934
<TOTAL-ASSETS>                              78,849,073
<CURRENT-LIABILITIES>                       27,947,673
<BONDS>                                     35,908,383
                                0
                                 10,000,000
<COMMON>                                       263,029
<OTHER-SE>                                   2,926,626
<TOTAL-LIABILITY-AND-EQUITY>                78,849,073
<SALES>                                     22,444,636
<TOTAL-REVENUES>                            22,444,636
<CGS>                                       12,371,748
<TOTAL-COSTS>                               16,221,379
<OTHER-EXPENSES>                             3,748,249
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           1,273,477
<INCOME-PRETAX>                              1,201,531
<INCOME-TAX>                                    23,789
<INCOME-CONTINUING>                          1,177,742
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 1,049,963
<EPS-BASIC>                                        .04
<EPS-DILUTED>                                      .04


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission